References
- Blais JE, Wu P. The impact of age, disease severity, and vaccination status on antibiotic use in hospitalized patients with COVID-19. Expert Opin Pharmacother. 2023. doi: 10.1080/14656566.2023.2270421
- Bassetti M, Brucci G, Vena A, et al. Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario. Expert Opin Pharmacother. 2023 Sep;24(15):1679–1684. doi: 10.1080/14656566.2023.2239154
- Blais JE, Zhang W, Lin Y, et al. Inpatient antibacterial drug prescribing for patients with COVID-19 in Hong Kong. medRxiv. 2023:2023.06.19.23291622.
- Alshaikh FS, Godman B, Sindi ON, et al. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis. PLoS One. 2022;17(8):e0272375. doi: 10.1371/journal.pone.0272375
- Giacobbe DR, Bassetti M. Too many antibiotics for patients with COVID-19 despite low bacterial infections. Lancet Infect Dis. 2023 Jan 27;23(6):636–637. doi: 10.1016/S1473-3099(22)00866-0
- Chen JZ, Hoang HL, Yaskina M, et al. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial. Lancet Infect Dis. 2023 Jan 27;23(6):673–682. doi: 10.1016/S1473-3099(22)00832-5